THERAPEUTIC POTENTIAL OF CHOLECYSTOKININ RECEPTOR ANTAGONISTS IN CNS DISORDERS

被引：10

作者：

SCHIANTARELLI, P

机构：

[1] Preclinical Research Division, Boehringer Ingelheim Italy, 20139 Milano

来源：

PHARMACOLOGICAL RESEARCH | 1993年 / 28卷 / 01期

关键词：

D O I：

10.1006/phrs.1993.1104

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1 / 9

页数：9

共 50 条

[21] INVOLVEMENT OF ENDOGENOUS BENZODIAZEPINE RECEPTOR LIGANDS IN BRAIN DISORDERS - THERAPEUTIC POTENTIAL FOR BENZODIAZEPINE ANTAGONISTS
POLC, P
MEDICAL HYPOTHESES, 1995, 44 (06) : 439 - 446
[22] CHOLECYSTOKININ RECEPTOR ANTAGONISTS - A REVIEW
SILVERMAN, MA
GREENBERG, RE
BANK, S
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (08): : 703 - 708
[23] Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds
Cai, Sui Xiong
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (07) : 651 - 662
[24] Therapeutic potential of adenosine receptor antagonists and agonists
Press, Neil J.
Gessi, Stefania
Borea, Pier A.
Polosa, Riccardo
EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (08) : 979 - 991
[25] Discovery and therapeutic potential of kinin receptor antagonists
Whalley, Eric T.
Figueroa, Carlos D.
Gera, Lajos
Bhoola, Kanti D.
EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (12) : 1129 - 1148
[26] Therapeutic potential of endothelin receptor antagonists in diabetes
Chakrabarti, S
Cukiernik, M
Mukherjee, S
Chen, SL
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (12) : 2873 - 2888
[27] Therapeutic potential of angiotensin II receptor antagonists
White, M
Racine, N
Ducharme, A
de Champlain, J
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (09) : 1687 - 1701
[28] Therapeutic potential for GIP receptor agonists and antagonists
Irwin, Nigel
Flatt, Peter R.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 499 - 512
[29] LEUKOTRIENE RECEPTOR ANTAGONISTS AS POTENTIAL THERAPEUTIC AGENTS
SNYDER, DW
FLEISCH, JH
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1989, 29 : 123 - 143
[30] Therapeutic potential of potassium channel modulators for CNS disorders
Clark, AG
Booth, SE
Morrow, JA
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (01) : 23 - 32

← 1 2 3 4 5 →